arrow
G

Gabriele Madonna

istituto nazionale tumori irccs fondazione g pascale
H指数:26
被引数:2,989

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI)

解析黑色素瘤中罕见BRAF突变的谱系:意大利黑色素瘤协作组(IMI)开展的一项全国性研究

2026-04-190
OAAI
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

Monson, K.R.; Ferguson, R.; Handzlik, J.E.; Morales, L.; Xiong, J.; Chat, V.; Dagayev, S.; Khodadadi-Jamayran, A.; Simpson, D.; Kazlow, E.; 等. 继承的线粒体遗传学作为预测黑色素瘤免疫检查点抑制疗效的指标。Nat. Med. 2025, 31, 2385–2396. [Google Scholar] [CrossRef]

2025-06-050
OAAI
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy

液体活检中的代谢组学特征与接受免疫检查点抑制剂治疗的转移性黑色素瘤患者的总生存期相关

2025-04-100
OA
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
2024-11-011
OAAI
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres (vol 22, 1, 2024)
2024-10-220
OAAI
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)

Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤术后的辅助治疗: 一项多中心,回顾性队列研究 (第65卷,102290,2023)

2024-05-010
OAAI
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
2024-01-064
OAAI
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
2023-11-274
OAAI
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤确定性手术后的辅助治疗: 一项多中心,回顾性队列研究

2023-11-017
OAAI
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition

种系免疫调节表达与检查点抑制引起的免疫相关毒性相关的数量性状基因座 (ieqtl)

2023-08-014
OA
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023-02-239
OAAI
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

免疫特征预测免疫检查点抑制剂治疗的癌症患者自身免疫毒性的发展

MED
IF11.8
2023-02-0148
OA
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
2022-11-017
OA
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd-4th, 2021, Italy)

黑色素瘤的观点: 黑色素瘤桥会议报告 (意大利2021年12月2至4日)

2022-09-042
OAAI